MarketInOut Stock Screener Log In | Sign Up
 

DBV Technologies S.A. ADR

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
DBV Technologies S.A. ADR stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization604.6 mln
Float54.19 mln
Earnings Date10/28/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

38.60
Transformational upside

Relative Strength

58 / 100
Slightly ahead

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-3,121%
Severely loss-making

ROE

-129
Deeply negative

Business Description

DBV Technologies is a French medical research company focused on developing new ways to treat food allergies by applying therapeutic patches directly to the skin. Its most advanced product targets peanut allergies and has completed a Phase 3 clinical trial, while another patch-based treatment for cow's milk allergy is currently in earlier-stage testing. The company also works with Nestlé Health Science to create a diagnostic tool that helps identify milk protein allergies in young children. Founded in 2002 and based near Paris, DBV Technologies continues to explore skin-based approaches as a broader platform for addressing food-related immune conditions.

Key Fundamentals

EPS-3.50
ROE-129
RPS0.09
ROIC-537
ROA-89.66
EBITDA, mln-162
EV / EBITDA-6.31
EV / EBIT-5.66
Revenue, mln5.04
EV / Revenue80.56

Quote Details

Last 9.75
Change 0.07 (0.72%)
Open 9.68
Volume 254,298
Turnover 2,479,406
Average Volume 446,578

Financial Ratios

Pre-Tax Profit Margin-3,121
Leverage Ratio1.39
Current Ratio3.72
Price / Book4.37
Price / Tangible Book4.37
Debt / Equity0.13
Price / Sales56.40

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price38.60
Short Ratio3.29
Short % of Float1.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.73% 92 / 100   
1 Month -15.95% 22 / 100   
2 Months -33.08% 15 / 100   
6 Months -50.76% 12 / 100   
1 Year -35.52% 23 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog